Recent Advances in Clinical Studies and the Evolving Role of Subtyping for Patients With Diffuse Large B-Cell Lymphoma

Future Oncology - United Kingdom
doi 10.2217/fon-2016-0567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma

2020English

Population Pharmacokinetics of Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Association With Clinical Outcome

British Journal of Clinical Pharmacology
Pharmacology
2017English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Clinical and Treatment-Related Features Determining the Risk of Late Relapse in Patients With Diffuse Large B-Cell Lymphoma

British Journal of Haematology
Hematology
2017English

The Role of Maintenance Therapy in Patients With Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Clinical and Hematological Predictors of Response to First-Line Therapy in Patients With Diffuse Large B-Cell Lymphoma

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy